Companies › Suzhou Abogen Biosciences
4 active drug programs in 7 registered trials: 4 Phase 1, 2 Phase 2, 1 Phase 3; Oncology, Infectious disease; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| ABO1108 Herpes zoster mRNA vaccine | – | Phase 3 | Varicella-zoster Virus | Feb 2027 |
| ABO1105 Respiratory Syncytial Virus mRNA vaccine | – | Phase 2 | Respiratory Syncytial Virus | Oct 2027 |
| ABO2011 mRNA encoding human single-chain IL-12 protein | IL12 | Phase 1 | Solid Tumor, Adult | Dec 2026 |
| ABO2102 Injection mRNA encoding mutant KRAS neoantigens | – | Phase 1 | Advanced / Metastatic Solid Tumor | Jun 2029 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT07289503 | ABO1105 | Phase 1 | Respiratory Syncytial Virus | Infectious disease | Sep 2025 |
| NCT07285265 | ABO1108 | Phase 1 | Varicella-zoster Virus | Infectious disease | Nov 2025 |
| NCT06088004 | ABO2011 | Phase 1 | Solid Tumor, Adult | Oncology | Dec 2026 |
| NCT07285278 | ABO1108 | Phase 2 | Varicella-zoster Virus | Infectious disease | Feb 2027 |
| NCT07289542 | ABO1105 | Phase 2 | Respiratory Syncytial Virus | Infectious disease | Oct 2027 |
| NCT07817108 | ABO1108 | Phase 3 | Varicella-zoster Virus | Infectious disease | Oct 2027 |
| NCT07455617 | ABO2102 Injection | Phase 1 | Advanced / Metastatic Solid Tumor | Oncology | Jun 2029 |
Strand Therapeutics Geneos Therapeutics Imunon VLP Therapeutics Sonnet BioTherapeutics Kangabio AUSTRALIA enGene Inovio Pharmaceuticals Trogenix
Geneos Therapeutics Imunon BioNTech SE Immorna Biotherapeutics Vir Biotechnology
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.